Please select an option below to help us tailor your newsletter to best suit your content interests!
HEALTHCARE HEROES We are so proud of Dr. Gregory Vidal and Parrish Throckmorton, PT for being nominated as Memphis Business Journal’s healthcare heroes! With 5 nominees in only 5 categories – our West family is elated to have 2 team members recognized for their efforts and relentless pursuit of excellence in healthcare, making them true… Read more »
Dr. Gregory Vidal is co-leading a groundbreaking study aimed at identifying barriers to health care for Black women in the Mid-South. This initiative, supported by a $1.58 million grant from Gilead Sciences, Inc., is a collaborative effort with Dr. Janeane Anderson from the University of Tennessee Health Science Center’s College of Nursing. This research seeks… Read more »
West Cancer Center & Research Institute proudly announces that two of their oncology providers, Dr. Michael Berry, Breast Oncology Surgeon and Dr. Gregory Vidal, Medical Oncologist and Director of Clinical Research recently visited Capitol Hill in Washington, DC. They engaged with lawmakers from across the state and political spectrum to address crucial issues affecting cancer… Read more »
🏆 20 West physicians have been named Castle Connolly Top Doctors 🏆 Castle Connolly’s Top Docs represent the ✨top 7%✨ of all U.S. practicing physicians! Selected through a rigorous process of peer nominations and thorough vetting by a physician-led research team, these doctors are truly top-notch healthcare providers. Their exceptional clinical care, specialty expertise, and… Read more »
An abstract created in partnership with Dr. Gregory Vidal and Dr. Andrea Curry of our West family about Addressing Breast Cancer Disparities has been officially accepted by San Antonio Breast Cancer Symposium Alongside Rabble Health and the Urban Health Education & Support Services, this team will present methods used to measurably address social determinants of… Read more »
Exciting Advances in Endocrine Therapies for Breast Cancer! 🌟 In a recent OncLive Peer Exchange, our very own Dr. Gregory Vidal shares a panel with Dr. Komal Jhaveri, Dr. Timothy Pluard, Dr. Aditya Bardia, and Dr. VK Gadi to discuss the promising landscape of novel endocrine drugs. Discussion highlights include: – The emergence of selective… Read more »
West Medical Oncologists, Dr. Bradley Somer and Dr. Gregory Vidal are two of the presenters for the upcoming Best of ASCO – Memphis Conference. Dr. Vidal will host two sessions: the SEEK Workshop Primer Panel and Diversity in Cancer Care, while Dr. Somer will host a session on GU Cancers. This Post ASCO Review will… Read more »
In a recent OncLive Peer Exchange, Dr. Gregory Vidal partnered with a panel of breast oncology experts to discuss the standard-of-care treatment approaches for early-stage HR-positive/HER2-negative breast cancer. Topics include: – Evolution of HER2-negative management – Updates in HR-positive treatment – Importance of genetic testing – Utilization of endocrine therapy – BRCA mutations and… Read more »
Through research and partnerships across the oncology community, we are committed to closing the gap in existing disparities in cancer care. A new study in partnership with Dr. Gregory Vidal and our West family, OneOncology, Genentech, and Flatiron Health examined elements of inequity in next generation sequencing (NGS) for patients with advanced non-small cell lung… Read more »
CONGRATULATIONS TO OUR TOP DOCTORS! Castle Connolly recently announced their 2023 #TopDoc picks, and 18 of our West physicians were selected. Of over 850,000 practicing providers in the U.S., our doctors were chosen though a rigorous 3rd party research process including study of their professional qualifications, education, appointments, leadership, reputation, and disciplinary history. Patients always… Read more »